These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 689042)

  • 21. Immune complexes in myasthenia gravis.
    Barkas T; Boyle RS; Behan PO
    J Clin Lab Immunol; 1981 Jan; 5(1):27-30. PubMed ID: 7218325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune disease and HLA associations with myasthenia gravis.
    Behan PO
    J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):611-21. PubMed ID: 6967515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attempts to implicate viruses in myasthenia gravis.
    Aoki T; Drachman DB; Asher DM; Gibbs CJ; Bahmanyar S; Wolinsky JS
    Neurology; 1985 Feb; 35(2):185-92. PubMed ID: 2982113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on HLA antigens and cellular and humoral autoimmune phenomena in patients with myasthenia gravis.
    Gross WL; Krüger J; Gröschel-Stewart U; Friedrich H; Kunze K
    Clin Exp Immunol; 1977 Jan; 27(1):48-54. PubMed ID: 849650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three cases of myasthenia gravis from one family with variations in clinical features and serum antibodies.
    Chen Y; Wang W; Wei D; Yang L
    Neuromuscul Disord; 2012 Mar; 22(3):286-8. PubMed ID: 22082588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strong association of HLA BW46 with juvenile onset myasthenia gravis in Hong Kong Chinese.
    Hawkins BR; Chan-Lui WY; Choi EK; Ho AY
    J Neurol Neurosurg Psychiatry; 1984 May; 47(5):555-7. PubMed ID: 6588146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Biermer's anemia, Hashimoto's thyroiditis, myasthenia and malignant thymoma. HLA B8, DR3, and DR5 antigens].
    Humbert P; Dupond JL; Mallet H; Leconte des Floris R
    Presse Med; 1984 Feb; 13(7):439. PubMed ID: 6230615
    [No Abstract]   [Full Text] [Related]  

  • 28. Myasthenia gravis. Antibodies to an acid-soluble antigen in striated muscle.
    Aarli JA
    Clin Exp Immunol; 1972 Mar; 10(3):453-61. PubMed ID: 4624498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follow-up study of muscle function in children of mothers with myasthenia gravis during pregnancy.
    Ahlsten G; Lefvert AK; Osterman PO; Stålberg E; Säfwenberg J
    J Child Neurol; 1992 Jul; 7(3):264-9. PubMed ID: 1634748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiacetylcholine receptor and antinuclear antibodies in myasthenia gravis. Correlation with HLA, sex and Gm.
    Warlow RS; Garlepp M; Feeney D; Kay P; Swanson N; Dawkins RL
    Exp Clin Immunogenet; 1985; 2(3):158-63. PubMed ID: 3917146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenetics of experimental autoimmune myasthenia gravis.
    Christadoss P
    Crit Rev Immunol; 1989; 9(4):247-78. PubMed ID: 2679661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis.
    Tüzün E; Saini SS; Ghosh S; Rowin J; Meriggioli MN; Christadoss P
    Neuromuscul Disord; 2006 Feb; 16(2):137-43. PubMed ID: 16427283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In silico study of potential autoimmune threats from rotavirus infection.
    Sarkar T; Das S; Nandy P; Bhowmick R; Nandy A
    Comput Biol Chem; 2014 Aug; 51():51-6. PubMed ID: 24929545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of alpha-bungarotoxin binding to acetylcholine receptors by antisera from animals with experimental autoimmune myasthenia gravis.
    Claudio T; Raftery MA
    J Supramol Struct; 1980; 14(3):267-79. PubMed ID: 6971372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of HLA-DQA1*0101/2 and DQB1*0502 with myasthenia gravis in southern Iranian patients.
    Yousefipour GA; Salami Z; Farjadian S
    Iran J Immunol; 2009 Jun; 6(2):99-102. PubMed ID: 19561379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of acetylcholine receptor antibodies in myasthenia gravis.
    Appel SH; Elias SB; Chauvin P
    Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytophilic antibodies in experimental autoimmune myasthenia gravis.
    Martinez RD; Tarrab-Hazdai R; Aharonov A; Fuchs S
    J Immunol; 1977 Jan; 118(1):17-20. PubMed ID: 830746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of thymic pathology with HLA in myasthenia gravis.
    Machens A; Löliger C; Pichlmeier U; Emskötter T; Busch C; Izbicki JR
    Clin Immunol; 1999 Jun; 91(3):296-301. PubMed ID: 10370374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunoreactivity, HL-A antigen frequencies and clinical disease course of myasthenia gravis].
    Gross WL; Krüger J; Stewart U; Häckell U; Kunze K
    Verh Dtsch Ges Inn Med; 1975; 81():1178-81. PubMed ID: 1229431
    [No Abstract]   [Full Text] [Related]  

  • 40. Myasthenia gravis and scleroderma.
    Bhalla R; Swedler WI; Lazarevic MB; Ajmani HS; Skosey JL
    J Rheumatol; 1993 Aug; 20(8):1409-10. PubMed ID: 8230029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.